Quadrant Capital Group LLC Prime Medicine, Inc. Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 966 shares of PRME stock, worth $2,801. This represents 0.0% of its overall portfolio holdings.

Number of Shares

966

Holding current value

$2,801

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 12, 2024	BUY	$3.41 - $6.7 $3,294 - $6,472	966 New	966 $3,000

Others Institutions Holding PRME

# of Institutions

123

Shares Held

64.7M

Call Options Held

324K

Put Options Held

64.4K

Alphabet Inc. Mountain View, CA

15.1M
Shares

$43.7 Million
3.99% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

5.66M
Shares

$16.4 Million
0.21% of portfolio
Black Rock Inc. New York, NY

5.11M
Shares

$14.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.89M
Shares

$14.2 Million
0.0% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

3.81M
Shares

$11 Million
0.01% of portfolio

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $278M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Prime Medicine, Inc. Transaction History